Pancreatic cancer immune landscape reveals opportunities for personalized therapies

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies.

Lykos Plots FDA Appeal: Reeling from CRL and Journal Article Retractions, MDMA Developer Hopes to Change Your Mind – Psychedelic Alpha

As I reported on Friday evening, Lykos looks set to appeal the FDA’s decision. The company said it will request a meeting with the agency to ask

August 13, 2024

BioCardia pauses enrollment in PhIII trial of heart failure stem cell therapy

BioCardia has paused enrollment in a pivotal study of its stem cell therapy for heart failure after an independent review board determined the trial was

July 25, 2023

Fighting Rectal Cancer with AI: Researchers Secure $2.78M Grant

What You Should Know: – A glimmer of hope emerged today for rectal cancer patients as a collaborative effort between Case Western Reserve University (CWRU),

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.